Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Firebird Global Master Fund is an investment vehicle managed by Firebird Management LLC, an SEC-registered investment advisor based in New York. The fund specializes in global equity investments, with a particular focus on emerging markets and specialized sectors such as biotechnology and life sciences. It frequently participates in private investment in public equity (PIPE) transactions and venture financing rounds for growth-stage healthcare companies. As an institutional investor, the fund is known for its long-term investment horizon and its role as a significant stakeholder in various publicly traded and private biotech firms. It does not develop its own therapeutic products but provides essential capital to the life sciences ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Firebird Global Master Fund.